Prognosis and Reclassification by YKL-40 in Stable Coronary Artery Disease

Autor: Julia S. Johansen, Jakob Schroder, Christian Gluud, Jens Kastrup, Gorm Boje Jensen, Jørgen Hilden, Janus Christian Jakobsen, Ahmad Sajadieh, Per Winkel, Johan Ärnlöv, Anders Larsson, Marina Harutyunyan, Erik Kjøller

Publikováno v: Schroder, J, Jakobsen, J C, Winkel, P, Hilden, J, Jensen, G B, Sajadieh, A, Larsson, A, Ärnlöv, J, Harutyunyan, M, Johansen, J S, Kjøller, E, Gluud, C & Kastrup, J 2020, ' Prognosis and Reclassification by YKL-40 in Stable Coronary Artery Disease ', Journal of the American Heart Association, vol. 9, no. 5, e014634 . https://doi.org/10.1161/JAHA.119.014634
Schroder, J, Jakobsen, J C, Winkel, P, Hilden, J, Jensen, G B, Sajadieh, A, Larsson, A, Ärnlöv, J, Harutyunyan, M, Johansen, J S, Kjøller, E, Gluud, C & Kastrup, J 2020, ' Prognosis and Reclassification by YKL-40 in Stable Coronary Artery Disease ', Journal of the American Heart Association, vol. 9, no. 5, e01463 . https://doi.org/10.1161/JAHA.119.014634
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease

Background The inflammatory biomarker YKL‐40 has previously been studied as a potential risk marker in cardiovascular disease. We aimed to assess the prognostic reclassification potential of serum YKL‐40 in patients with stable coronary artery di

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f3b7b128b333e60029bdab797a4a675e
http://urn.kb.se/resolve?urn=urn:nbn:se:du-32335

The influence of contrast media on kidney function in patients with stable coronary artery disease

Autor: Simon Bertram Reuter, Erik Jørgensen, Jens Kastrup, Naja Dam Mygind, Marina Harutyunyan

Publikováno v: Scandinavian Cardiovascular Journal. 48:234-240

To investigate the incidence of contrast media-induced nephropathy (CIN) in patients with stable coronary artery disease (CAD) referred for elective coronary intervention following hydration routines. The reversibility of CIN was followed in a 6 mont

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::87b4edbb05f16ef956baa7c890303516
https://doi.org/10.3109/14017431.2014.934713

Serum YKL-40 predicts long-term mortality in patients with stable coronary disease: a prognostic study within the CLARICOR trial

Autor: Erik Kjøller, Per Winkel, Jens Kastrup, Marina Harutyunyan, Christian Gluud, Jørgen Hilden, Jens Peter Gøtze, Julia S. Johansen, Hans Jørn Kolmos, Gorm B. Jensen, Jørgen Fischer Hansen

Publikováno v: Harutyunyan, M, Gøtze, J P, Winkel, P, Johansen, J S, Hansen, J F, Jensen, G B, Hilden, J, Kjøller, E, Kolmos, H J, Gluud, C & Kastrup, J 2013, ' Serum YKL-40 predicts long-term mortality in patients with stable coronary disease : a prognostic study within the CLARICOR trial ', Immunobiology, vol. 218, no. 7, pp. 945-51 . https://doi.org/10.1016/j.imbio.2012.10.015

We investigated whether the inflammatory biomarker YKL-40 could improve the long-term prediction of death made by common risk factors plus high-sensitivity C-reactive protein (hs-CRP) and N-terminal-pro-B natriuretic peptide (NT-proBNP) in patients w

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9084ae8d74e16b06377af673cc5f1804
https://pubmed.ncbi.nlm.nih.gov/23294528

High-sensitivity C-reactive protein and N-terminal pro-B-type natriuretic peptide in patients with stable coronary artery disease: a prognostic study within the CLARICOR trial

Autor: Jens Kastrup, Hans Jørn Kolmos, Per Winkel, Jens Peter Gøtze, Gorm B. Jensen, Erik Kjøller, Jørgen Fischer Hansen, Jørgen Hilden, Per Hildebrandt, Marina Harutyunyan, Christian M. Jespersen, Christian Gluud, Anders Bruun Mathiasen

Publikováno v: Harutyunyan, M J, Mathiasen, A B, Winkel, P, Gøtze, J P, Hansen, J F, Hildebrandt, P, Jensen, G B, Hilden, J, Jespersen, C M, Kjøller, E, Kolmos, H J, Gluud, C N & Kastrup, J 2011, ' High-sensitivity C-reactive protein and N-terminal pro-B-type natriuretic peptide in patients with stable coronary artery disease: a prognostic study within the CLARICOR Trial ', Scandinavian Journal of Clinical and Laboratory Investigation. Supplement, vol. 71, no. 1, pp. 52-62 . https://doi.org/10.3109/00365513.2010.538081

Background. Patients with stable coronary artery disease (CAD) have a poor prognosis. The aim of the study was to evaluate the extent to which serum high-sensitivity C-reactive protein (hs-CRP) and N-terminal pro-B-type natriuretic peptide (NT-proBNP

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ad7663b513228120d937bb510f62889a
https://pubmed.ncbi.nlm.nih.gov/21108561

SERUM YKL-40 IS ASSOCIATED WITH LONG-TERM MORTALITY IN PATIENTS WITH STABLE COROONARY DISEASE: A PROGNOSTIC STUDY WITHIN THE CLARICOR TRIAL

Autor: Per Winkel, Christian Gluud, Jens Kastrup, Julia S. Johansen, Gorm B. Jensen, Marina Harutyunyan, Jørgen Fischer Hansen, Jens P. Goetze, Erik Kjøller, Hans Joern Kolmos, Joergen Hilden

Publikováno v: Journal of the American College of Cardiology. 59:E1474

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::597644547aac67a5623fe1b24afb5e26
https://doi.org/10.1016/s0735-1097(12)61475-2